FDA Issues New, Enhanced Warnings for Levaquin & Other Fluoroquinolone Antibiotics
Days ago, regulators at the U.S. Food and Drug Administration (FDA) issued a new warning for Levaquin and other fluoroquinolone antibiotics, alerting the public that these drugs have been linked to “disabling and potentially permanent side effects.” As part of this alert, regulators also announced that they have approved stricter warning labels for fluoroquinolone antibiotics [...]